CNAT - Conatus Pharmaceuticals Inc.
Previous close
0.556
0.556 100.000%
Share volume: 0
Last Updated: Tue 26 May 2020 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
40%
Profitability
51%
Dept financing
32%
Liquidity
42%
Performance
31%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.31%
Return on assets
-10.03%
Return on sales
0%
Return on invested capital
87.17%
Total debt ratio
46.09%
Debt ratio change over timeo
1.37%
Current Ratio
5.07%
Quick Ratio
0%
Cash Position Ratio
3.03%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.69%
Return on assets
-11.85%
Return on sales
0%
Return on invested capital
159.93%
Total debt ratio
15.71%
Debt ratio change over timeo
-0.03%
Current Ratio
9.64%
Quick Ratio
0%
Cash Position Ratio
8.48%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-19.73%
Return on assets
-19.16%
Return on sales
0%
Return on invested capital
348.8%
Total debt ratio
6.09%
Debt ratio change over time
-0.97%
Current Ratio
16.28%
Quick Ratio
0%
Cash Position Ratio
15.76%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-180.43%
Return on assets
-138.37%
Return on sales
0%
Return on invested capital
95.64%
Total debt ratio
137.08%
Debt ratio change over time
1.37%
Current Ratio
16.32%
Quick Ratio
0%
Cash Position Ratio
7.3%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CNAT | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -19.31% | -40.8% | -11.36% | -12.25% |
| Return on assets | -10.03% | -19.78% | -8.97% | -9.49% |
| Return on sales | 0% | -5539.23% | 0% | -349.39% |
| Return on invested capital | 87.17% | 342.85% | -123.82% | -117.39% |
| Profitability | 31% | 25% | 50% | 0% |
| Total debt ratio | 46.09% | 121.38% | 25.26% | 26.21% |
| Debt ratio change over time | 1.37% | -0.12% | -1.11% | -1.45% |
| Dept financing | 34% | 25% | 5% | 5% |
| Current Ratio | 9.64% | 8.43% | 6.41% | 5.11% |
| Quick Ratio | 0% | 0% | 0% | 4.79% |
| Cash Position Ratio | 8.48% | 8.13% | 3.15% | 1.72% |
| Liquididy | 24% | 48% | 25% | 59% |
| Short-term ratios | CNAT | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -12.69% | -135.01% | -20.23% | -17.62% |
| Return on assets | -11.85% | -15.63% | -15.18% | -9.31% |
| Return on sales | 0% | 0% | 0% | -398.97% |
| Return on invested capital | 159.93% | 435.95% | 248.95% | -45.1% |
| Profitability | 59% | 25% | 14% | 25% |
| Total debt ratio | 15.71% | 74.66% | 29.16% | 48.64% |
| Debt ratio change over time | -0.03% | -0.82% | -1.48% | -2.29% |
| Dept financing | 30% | 25% | 10% | 16% |
| Current Ratio | 9.64% | 8.43% | 6.41% | 5.11% |
| Quick Ratio | 0% | 0% | 0% | 4.79% |
| Cash Position Ratio | 8.48% | 8.13% | 3.15% | 1.72% |
| Liquididy | 50% | 46% | 26% | 43% |